Amdocs Net Interest Income vs Depreciation And Amortization Analysis
DOX Stock | USD 84.98 0.66 0.77% |
Amdocs financial indicator trend analysis is way more than just evaluating Amdocs prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amdocs is a good investment. Please check the relationship between Amdocs Net Interest Income and its Depreciation And Amortization accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.
Net Interest Income vs Depreciation And Amortization
Net Interest Income vs Depreciation And Amortization Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amdocs Net Interest Income account and Depreciation And Amortization. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Amdocs' Net Interest Income and Depreciation And Amortization is -0.39. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Depreciation And Amortization in the same time period over historical financial statements of Amdocs, assuming nothing else is changed. The correlation between historical values of Amdocs' Net Interest Income and Depreciation And Amortization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Amdocs are associated (or correlated) with its Depreciation And Amortization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation And Amortization has no effect on the direction of Net Interest Income i.e., Amdocs' Net Interest Income and Depreciation And Amortization go up and down completely randomly.
Correlation Coefficient | -0.39 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Depreciation And Amortization
The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.Most indicators from Amdocs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amdocs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.At this time, Amdocs' Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 14.45 in 2024, whereas Selling General Administrative is likely to drop slightly above 390.6 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.6B | 1.7B | 2.0B | 1.1B | Total Revenue | 4.6B | 4.9B | 5.6B | 3.1B |
Amdocs fundamental ratios Correlations
Click cells to compare fundamentals
Amdocs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Amdocs fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.3B | 6.5B | 6.4B | 6.4B | 7.4B | 4.5B | |
Other Current Liab | 794.4M | 886.6M | 821.3M | 849.4M | 976.9M | 1.0B | |
Total Current Liabilities | 1.2B | 1.3B | 1.3B | 1.4B | 1.6B | 1.0B | |
Total Stockholder Equity | 3.6B | 3.6B | 3.5B | 3.5B | 4.1B | 2.8B | |
Property Plant And Equipment Net | 903.4M | 931.9M | 971.2M | 951.9M | 1.1B | 1.1B | |
Net Debt | 50.0M | 172.1M | 253.5M | 287.2M | 258.5M | 271.4M | |
Retained Earnings | 5.3B | 5.9B | 6.2B | 6.5B | 7.5B | 7.9B | |
Accounts Payable | 930.3M | 121.2M | 134.4M | 293.3M | 337.3M | 428.4M | |
Cash | 983.2M | 709.1M | 573.4M | 520.1M | 598.1M | 720.1M | |
Non Current Assets Total | 4.3B | 4.4B | 4.4B | 4.5B | 5.2B | 2.6B | |
Non Currrent Assets Other | 488.6M | 630.7M | 574.9M | 631.6M | 726.3M | 762.6M | |
Cash And Short Term Investments | 983.9M | 965.6M | 818.0M | 742.5M | 853.9M | 1.0B | |
Net Receivables | 861.0M | 866.8M | 946.8M | 944.5M | 1.1B | 618.6M | |
Common Stock Shares Outstanding | 133.2M | 128.0M | 121.9M | 118.5M | 106.6M | 144.3M | |
Liabilities And Stockholders Equity | 6.3B | 6.5B | 6.4B | 6.4B | 7.4B | 4.5B | |
Non Current Liabilities Total | 1.5B | 1.6B | 1.6B | 1.5B | 1.7B | 1.8B | |
Other Current Assets | 229.6M | 235.1M | 238.4M | 224.6M | 258.3M | 307.0M | |
Other Stockholder Equity | (1.7B) | (2.3B) | (2.6B) | (3.0B) | (2.7B) | (2.5B) | |
Total Liab | 2.7B | 2.9B | 2.8B | 2.9B | 3.3B | 1.7B | |
Total Current Assets | 2.1B | 2.1B | 2.0B | 1.9B | 2.2B | 1.9B | |
Short Term Debt | 159.1M | 58.7M | 43.3M | 40.0M | 46.0M | 43.7M | |
Property Plant And Equipment Gross | 903.4M | 931.9M | 971.2M | 951.9M | 1.1B | 1.1B | |
Accumulated Other Comprehensive Income | 11.7M | 9.3M | (72.5M) | (53.3M) | (47.9M) | (45.5M) | |
Common Stock | 4.5M | 4.5M | 4.5M | 4.6M | 5.3M | 4.4M | |
Current Deferred Revenue | 126.8M | 237.4M | 253.7M | 170.6M | 196.2M | 184.3M | |
Other Liab | 542.4M | 586.2M | 750.3M | 793.9M | 913.0M | 469.4M | |
Other Assets | 423.9M | 488.6M | 630.7M | 574.9M | 661.2M | 386.6M | |
Good Will | 2.6B | 2.6B | 2.7B | 2.7B | 3.2B | 1.9B | |
Intangible Assets | 296.3M | 259.0M | 178.3M | 181.5M | 163.4M | 317.6M | |
Property Plant Equipment | 354.0M | 723.6M | 931.9M | 971.2M | 1.1B | 1.2B | |
Short Term Investments | 752K | 256.5M | 244.6M | 222.5M | 200.2M | 266.3M | |
Net Tangible Assets | 660.6M | 567.8M | 711.0M | 676.6M | 609.0M | 676.1M |
Pair Trading with Amdocs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.Moving together with Amdocs Stock
0.63 | S | SentinelOne Financial Report 6th of June 2024 | PairCorr |
0.63 | MQ | Marqeta Financial Report 14th of May 2024 | PairCorr |
Moving against Amdocs Stock
0.8 | NN | Nextnav Acquisition Corp Upward Rally | PairCorr |
0.65 | EGIO | Edgio Inc Report 17th of July 2024 | PairCorr |
0.61 | GB | Global Blue Group | PairCorr |
0.5 | VERI | Veritone Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amdocs. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Amdocs Stock analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.18 | Dividend Share 1.74 | Earnings Share 4.68 | Revenue Per Share 41.665 | Quarterly Revenue Growth 0.05 |
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.